Australia: Clarification on quality standards, use of synthetics, and labelling and packaging requirements for medicinal cannabis products April 29, 2022 By Helen Macpherson, Alanna Rennie and Anita Juric 1 Min Read Share Share on Facebook Share on Twitter Email Baker McKenzie’s Global Compliance News Blog published “Australia: Clarification on quality standards, use of synthetics, and labelling and packaging requirements for medicinal cannabis products,” which can be viewed here. 0 Author Helen Macpherson Author Alanna Rennie Author Anita Juric Related Posts Europe: European Commission adopts a proposal of Directive on Corporate Sustainability Due Diligence May 19, 2022 Japan: First antitrust parallel imports case resolved under commitment procedures May 19, 2022 Italy: Publication of Annex 21 to the Good Manufacturing Practice Guidelines on the import of medicinal products May 16, 2022
Europe: European Commission adopts a proposal of Directive on Corporate Sustainability Due Diligence May 19, 2022
Italy: Publication of Annex 21 to the Good Manufacturing Practice Guidelines on the import of medicinal products May 16, 2022
